We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUG icon
801
Plug Power
PLUG
$3.04B
$28K ﹤0.01%
+846
New +$19.2K
RPTX
802
DELISTED
Repare Therapeutics
RPTX
$28K ﹤0.01%
+845
New +$25.2K
IMGN
803
DELISTED
Immunogen Inc
IMGN
$28K ﹤0.01%
4,370
+2,880
+193% +$16.8K
BKI
804
DELISTED
Black Knight, Inc. Common Stock
BKI
$28K ﹤0.01%
320
-914
-74% -$83K
AVLR
805
DELISTED
Avalara, Inc.
AVLR
$28K ﹤0.01%
+170
New +$27.2K
ALEC icon
806
Alector
ALEC
$199M
$27K ﹤0.01%
1,840
+1,164
+172% +$14.5K
ITOS
807
DELISTED
iTeos Therapeutics
ITOS
$27K ﹤0.01%
+805
New +$21.3K
KRRO icon
808
Korro Bio
KRRO
$195M
$27K ﹤0.01%
+16
New +$21.1K
KRYS icon
809
Krystal Biotech
KRYS
$9.66B
$27K ﹤0.01%
+450
New +$22.5K
PKG icon
810
Packaging Corp of America
PKG
$22.8B
$27K ﹤0.01%
197
+61
+45% +$7.68K
WAB icon
811
Wabtec
WAB
$49.3B
$27K ﹤0.01%
379
+107
+39% +$7.32K
OPTU
812
Optimum Communications Inc
OPTU
$301M
$26K ﹤0.01%
709
+165
+30% +$5.17K
BDTX icon
813
Black Diamond Therapeutics
BDTX
$112M
$26K ﹤0.01%
+825
New +$27.1K
CHRW icon
814
C.H. Robinson
CHRW
$17.5B
$26K ﹤0.01%
283
+79
+39% +$7.54K
KPTI icon
815
Karyopharm Therapeutics
KPTI
$48M
$26K ﹤0.01%
113
+71
+169% +$16.5K
MOH icon
816
Molina Healthcare
MOH
$10.3B
$26K ﹤0.01%
126
+58
+85% +$12K
PASG icon
817
Passage Bio
PASG
$14.1M
$26K ﹤0.01%
+52
New +$20.8K
TBPH icon
818
Theravance Biopharma
TBPH
$877M
$26K ﹤0.01%
1,465
+923
+170% +$16.6K
FDS icon
819
Factset
FDS
$10.2B
$25K ﹤0.01%
78
+10
+15% +$3.31K
GEN icon
820
Gen Digital
GEN
$17.5B
$25K ﹤0.01%
1,219
+267
+28% +$5.39K
JKHY icon
821
Jack Henry & Associates
JKHY
$11.1B
$25K ﹤0.01%
159
+57
+56% +$9.05K
WPC icon
822
W.P. Carey
WPC
$16.4B
$25K ﹤0.01%
372
+94
+34% +$6.28K
EPZM
823
DELISTED
Epizyme, Inc
EPZM
$25K ﹤0.01%
2,330
+1,464
+169% +$18.1K
ZGNX
824
DELISTED
Zogenix, Inc.
ZGNX
$25K ﹤0.01%
1,275
+801
+169% +$16.4K
ADVM
825
DELISTED
Adverum Biotechnologies
ADVM
$24K ﹤0.01%
224
+143
+177% +$17.7K

Similar funds

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.